Related Experiment Video
Updated: Jun 16, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetics of osteoporosis: accelerating pace in gene identification and validation
Wen-Feng Li1, Shu-Xun Hou, Bin Yu
1Department of Orthopaedics, The First Affiliated Hospital, General Hospital of the People's Liberation Army, 100037 Beijing, China.
Human Genetics
|January 27, 2010
Summary
Osteoporosis genetics research has accelerated, identifying 15 confirmed and over 30 promising susceptibility genes. These genes are linked to key pathways, offering new therapeutic targets for this common bone disorder.
Area of Science:
- Genetics
- Metabolic Bone Disorders
- Osteoporosis Research
Background:
- Osteoporosis is a prevalent metabolic bone disorder characterized by low bone density and structural deterioration, increasing fracture risk.
- It affects a significant portion of the population over 50, particularly women.
- Recent advancements have accelerated the identification of osteoporosis susceptibility genes.
Purpose of the Study:
- To review and consolidate recent findings on osteoporosis susceptibility genes.
- To identify confirmed and candidate genes associated with osteoporosis.
- To explore the biological pathways implicated in osteoporosis pathogenesis.
Main Methods:
- Comprehensive review of genetic association studies, meta-analyses, and genome-wide association studies (GWAS).
- Analysis of single nucleotide polymorphisms (SNPs) and copy number variations (CNVs).
- Identification and categorization of osteoporosis susceptibility genes and their associated pathways.
Main Results:
- At least 15 genes are confirmed osteoporosis susceptibility genes (e.g., VDR, ESR1, LRP5, SOST, OPG, RANKL).
- Over 30 additional genes are identified as promising candidates.
- Confirmed and candidate genes are primarily associated with the estrogen, Wnt/beta-catenin, and RANKL/RANK/OPG pathways.
Conclusions:
- Genetic research has significantly advanced the understanding of osteoporosis.
- Identified genes and pathways provide novel targets for therapeutic and preventive strategies.
- Further gene discovery is expected to reveal additional biological pathways involved in osteoporosis.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...